Clozapine: Agonistic and antagonistic salivary secretory actions

Journal of Dental Research

Volumn 89, Issue 3, 2010, Pages 276-280

  Ekstrom J ^a   Godoy, T ^a   Riva, A ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Clozapine; Salivary secretion; Schizophrenia; Sialorrhea

Indexed keywords

BETA ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLOZAPINE; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT;

ANIMAL; ARTICLE; AUTONOMIC DENERVATION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HYPERSALIVATION; INNERVATION; PAROTID GLAND; RAT; SALIVA; SALIVATION; SECRETION; SPRAGUE DAWLEY RAT; SUBMANDIBULAR GLAND;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTONOMIC DENERVATION; CHOLINERGIC AGENTS; CLOZAPINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; PAROTID GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; SALIVA; SALIVATION; SIALORRHEA; SUBMANDIBULAR GLAND;

EID: 77149153568     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034509356055     Document Type: Article

References (28)

1. Alm P., Ekström J. (1977). On the adrenergic innervation of the rat parotid gland. Experientia 33: 523-524.
2. Anderson LC, Garrett JR, Proctor GB (1988). Advantages of burst stimulation for inducing sympathetic salivary secretion in rats. Q J Exp Physiol 73: 1025-1028.
3. Baldessarini RJ, Centorrino F., Flood JG, Volpicelli SA, Huston-Lyons D., Cohen BM (1993). Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9: 117-124.
4. Ben-Aryeh H., Jungerman T., Szargel R., Klein E., Laufer D. (1996). Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry 39: 946-949.
5. Eiermann B., Engel G., Johansson I., Zanger UM, Bertilsson L. (1997). The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharmacol 44: 439-446.
6. Ekström J. (1980). Sensitization of the rat parotid gland to secretagogues following either parasympathetic denervation or sympathetic denervation or decentralization. Acta Physiol Scand 108: 253-261.
7. Ekström J. (1999 a). Role of nonadrenergic, noncholinergic autonomic transmitters in salivary glandular activities in vivo. In: Neural mechanisms of salivary glands. Frontiers of oral biology. Vol. 11. Garrett JR, Ekström J, Anderson LC, editors. Basel: Karger, pp. 94-130.
8. Ekström J. (1999 b). Degeneration secretion and supersensitivity in salivary glands following denervations, and the effects on choline acetyltransferase activity. In: Neural mechanisms of salivary glands. Frontiers of oral biology. Vol. 11. Garrett JR, Ekström J, Anderson LC, editors. Basel: Karger, pp. 166-184.
9. Ekström J., Malmberg L. (1981). Preponderance for either α- or β-adrenoceptor mediated sensitization in the rat submandibular gland. Acta Physiol Scand 113: 103-110.
10. Emmelin N. (1961). Supersensitivity following "pharmacological denervation ". Pharmacol Rev 13: 17-37.
11. Hector MP, Linden RWA (1999). Reflexes of salivary secretion. In: Neural mechanisms of salivary glands. Frontiers of oral biology. Vol. 11. Garrett JR, Ekström J, Anderson LC, editors. Basel: Karger, pp. 196-217.
12. Khosravani N., Sandberg M., Ekström J. (2006). The otic ganglion and its parotid connection: cholinergic pathways, reflex secretion and a secretory role for the facial nerve. Exp Physiol 91: 239-247 ; erratum in Exp Physiol 91: 481, 2006.
13. Lameh J., Burstein ES, Taylor E., Weiner DM, Vanover KE, Bonhaus DW (2007). Pharmacology of N-desmethylclozapine. Pharmacol Therap 115: 223-231.
14. Lung MA (1990). Variations in blood flow on mandibular glandular secretion to autonomic nervous stimulations in anaesthetized dogs. J Physiol (Lond) 431: 479-493.
15. McCarthy R., Terkelsen K. (1994). Oesophageal dysfunction in two patients after clozapine treatment [letter]. J Clin Psychopharmacol 14: 281-283.
16. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosencheck RA, et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 163: 600-610.
17. Pearlman C. (1994). Clozapine, nocturnal sialorrhea, and choking [letter]. J Clin Psychopharmacol 14: 283.
18. Pochet S., Garcia-Marcos M., Fernandez M., Marino A., Dehaye JP (2003). Regulation by clozapine of calcium handling by rat submandibular acinar cells. Cell Calcium 34: 465-475. (Pubitemid 37493344)
19. Praharaj SK, Arora M., Gandrota S. (2006). Clozapine-induced sialorrhea: pathophysiology and management strategies. Psychopharmacology 185: 265-273.
20. Rabinowitz R., Frankenburg F., Centorrino F., Kando J. (1996). The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry 40: 1132-1134.
21. Riva A., Puxeddu R., Loy F., Isola M., Cabras T., Testa Riva F. (2003). Serous and mucous cells of human submandibular salivary gland stimulated in vitro by isoproterenol, carbachol and clozapine: an LM, TEM and HRSEM study. Eur J Morphol 41: 83-87.
22. Ryberg AT, Warfvinge G., Axelsson L., Soukup O., Götrick B., Tobin G. (2008). Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Arch Oral Biol 53: 66-74.
23. Sockalingam S., Shammi C., Remington G. (2007). Clozapine-induced hyper-salivation: a review of treatment strategies. Can J Psychiatry 52: 377-384.
24. Sun L., Lau CE (2000). Intravenous and oral clozapine pharmacokinetics, pharmacodynamics, and concentration-effect relations: acute tolerance. Eur J Pharmacol 398: 225-238.
25. Taylor D., Paton C., Kerwin R. (2005). The Maudsley 2005-2006 prescribing guidelines, 8 th ed. London: Taylor & Francis Ltd.
26. Testa Riva F., Puxeddu R., Loy F., Conti G., Riva A. (2006). Cytomorphological study on human submandibular gland following treatment with secretagogue drugs. Cell Tissue Res 324: 347-352.
27. Tobin G., Giglio D., Lundgren O. (2009). Muscarinic receptor subtypes in the alimentary tract J Physiol Pharmacol 60: 3-21.
28. Weiner DM, Meltzer HY, Veinbergs I., Donohue EM, Spalding TA, Smith TT, et al. (2004). The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. Psychopharmacology (Berl) 177: 207-216.